PON1 and neoplasm: Differences in PON1 expression influenced the clinical manifestations, biological processes, immune infiltration, and expression of immune checkpoints in HCC, suggesting that PON1 plays an important role in modulating tumor progression and immune cell infiltration, thus establishing PON1 as a new biomarker important for prognosis, targeted therapy, and immunotherapy in HCC patients [34].